Around The State

Home/Around The State

SLU Scientist Tackles Debilitating Side Effects of Cancer and Pain Medications

With a pair of RO1 grants from the National Institutes of Health, pain researcher Daniela Salvemini, Ph.D., will embark on two new research projects, studying chemotherapy-induced cognitive impairment, or “chemo brain,” symptoms and unwanted side effects of opioids.  Salvemini, who is professor of pharmacology and physiology at Saint Louis University, has spent her career attempting

Siteman Cancer Center to offer newest form of proton therapy

Cancer patients in Missouri, Southern Illinois and beyond will have access to a new generation of proton therapy in early 2020. Known as pencil-beam scanning, the technology delivers extremely precise treatments of proton therapy, a type of radiation therapy used to treat cancers of the head, chest, spine and other particularly sensitive areas, as well

October 23rd, 2018|Categories: Around The State, Cancer, Disease Specific|Tags: , |

Implantable, biodegradable devices speed nerve regeneration in rats

Car accidents, sports injuries, even too much typing and texting can injure the peripheral nerves, leaving people with numbness, tingling and weakness in their hands, arms or legs. Recovery can take months, and doctors have little to offer to speed it along. Now, researchers at Washington University School of Medicine in St. Louis and Northwestern

October 8th, 2018|Categories: Around The State, Disease Specific|Tags: |

MU-led Research Team Receives Nearly $4 Million from Department of Defense

Traumatic brain injuries (TBI) contribute to nearly 30 percent of all injury-related deaths in the United States, according to the Centers for Disease Control and Prevention. While the effects of TBI on behavioral and cognitive function are widely studied, the effects such injuries may have on the heart have yet to be determined. A research

September 28th, 2018|Categories: Around The State|Tags: , , |

Surgery Remains Best Option for Rare Bladder Cancer

In a recent paper published in the World Journal of Urology, Saint Louis University researchers reviewed data for patients with a rare type of bladder cancer, examining the treatments they received and the subsequent five-year-survival rates. Zachary Hamilton, M.D., assistant professor of urologic surgery at SLU and a SLUCare urologic oncologist, reports that surgery for

September 28th, 2018|Categories: Around The State, Cancer, Disease Specific|Tags: , |

SLU Researcher Receives $2.3 Million NIH Grant to Expand Youth-Friendly HIV Self-Testing

Nigerian youth are at the epicenter of an expanding HIV crisis in Sub-Saharan Africa. As a country, Nigeria ranks second in the in the world in new HIV-Infections among youth, youth living with HIV and AIDS-related death among a youth population. HIV testing is an important early entry point to accessing preventive education, care and

September 25th, 2018|Categories: Around The State, Disease Specific, HIV|Tags: , , , |

Washington University joins network for solving rare medical mysteries

Washington University School of Medicine in St. Louis is joining a national research network aimed at diagnosing rare, previously undescribed diseases in patients whose conditions present as medical mysteries. The Undiagnosed Diseases Network is made up of 12 clinical sites and several research centers across the country and funded by the National Institutes of Health

September 25th, 2018|Categories: Around The State|Tags: |

Study IDs why some TB bacteria prove deadly

People who fall sick with drug-resistant tuberculosis (TB) face daunting odds. Only about two in three survive the illness, unlike people with drug-sensitive TB, of whom more than 90 percent survive. Part of the reason drug-resistant TB is so lethal is because some antibiotics of first choice don’t kill the TB bacteria, forcing doctors to

September 20th, 2018|Categories: Around The State|Tags: , |

New clues found to understanding relapse in breast cancer

A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia. The knowledge could

September 20th, 2018|Categories: Around The State, Cancer|Tags: , |

Scientists identify weak point in deadly eye melanoma

A natural plant compound exploits a newly identified Achilles’ heel in a cancer of the eye, uveal melanoma. In human cancer cells growing in the lab, the compound shuts down the overactive signaling that drives uveal melanoma cell growth, according to researchers at Washington University School of Medicine in St. Louis. The study is published

September 20th, 2018|Categories: Around The State, Cancer, Disease Specific|Tags: , , |